Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

GXO Reaffirms 2024 Guidance

Author: Benzinga Newsdesk | August 06, 2024 06:32am
  • Organic revenue growth1 of 2% to 5%;
  • Adjusted EBITDA1 of $805 million to $835 million;
  • Adjusted diluted EPS1 of $2.73 to $2.93; and
  • Free cash flow conversion1 of 30% to 40% of adjusted EBITDA1.

Posted In: GXO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist